New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
13:43 EDTJNJJanssen says FDA approves broader indication for Zytiga
Janssen announced that the U.S. FDA has approved a broader indication for the oral, once-daily medication Zytiga. Until now, Zytiga with prednisone has only been approved to treat men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel. With this approval, Zytiga, in combination with prednisone, may now be used earlier in the treatment continuum for metastatic castration-resistant disease, before the use of chemotherapy. Zytiga also received a positive opinion for an expanded indication from the European Medicines Agency's Committee for Medicinal Products for Human Use nd is under review by other health authorities worldwide.
News For JNJ From The Last 14 Days
Check below for free stories on JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 17, 2013
06:19 EDTJNJJ&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information
May 15, 2013
16:51 EDTJNJFDA approves Simponi to treat ulcerative colitis
Subscribe for More Information
May 10, 2013
11:48 EDTJNJDrugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information
06:16 EDTJNJObesity surgery booming in India, Bloomberg reports
Subscribe for More Information
May 9, 2013
17:09 EDTJNJJohnson & Johnson deal to settle sales practices probe stalls, WSJ reports
Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link
09:51 EDTJNJJ&J unit says first patient enrolled in reMARQable study
Subscribe for More Information
May 8, 2013
07:38 EDTJNJBofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information
May 6, 2013
11:29 EDTJNJJ&J cosmetics license revoked at Mumbai plant, Reuters says
Subscribe for More Information
07:24 EDTJNJDrug companies attempt to make painkillers that can't be abused, WSJ reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.